This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
The new delivery system improved T cell priming and antitumoral response in a mouse model.
Why it matters
Improving peptide vaccine delivery could significantly enhance cancer immunotherapy outcomes. This method addresses challenges in vaccine transport and immune activation.
How the study worked
The study involved creating a peptide-STINGΔTM-cGAMP complex and testing its effectiveness in vitro and in vivo using a mouse model.
What this study cannot tell us
The study was conducted in mice, and results may not directly translate to humans.
Read the original research
Peptide-Based Cancer Vaccine Delivery via the STINGΔTM-cGAMP Complex.
Advanced healthcare materials, 11(15), e2200905
Citation
He, Yanpu; Hong, Celestine; Fletcher, Samantha J; Berger, Adam G; Sun, Xin; Yang, Mengdi; Huang, Shengnan; Belcher, Angela M; Irvine, Darrell J; Li, Jiahe; Hammond, Paula T. (2022). Peptide-Based Cancer Vaccine Delivery via the STINGΔTM-cGAMP Complex.. Advanced healthcare materials, 11(15), e2200905. https://doi.org/10.1002/adhm.202200905